- Home
- ULY vs SXTP Comparison
ULY vs SXTP Comparison
Compare ULY & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULY
- SXTP
- Stock Information
- Founded
- ULY 2013
- SXTP 2010
- Country
- ULY United States
- SXTP United States
- Employees
- ULY N/A
- SXTP N/A
- Industry
- ULY
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- ULY
- SXTP Health Care
- Exchange
- ULY Nasdaq
- SXTP Nasdaq
- Market Cap
- ULY 5.8M
- SXTP 6.7M
- IPO Year
- ULY N/A
- SXTP 2023
- Fundamental
- Price
- ULY $2.53
- SXTP $1.26
- Analyst Decision
- ULY Strong Buy
- SXTP Buy
- Analyst Count
- ULY 2
- SXTP 2
- Target Price
- ULY $11.50
- SXTP $3.00
- AVG Volume (30 Days)
- ULY 87.1K
- SXTP 282.2K
- Earning Date
- ULY 11-12-2025
- SXTP 11-14-2025
- Dividend Yield
- ULY N/A
- SXTP N/A
- EPS Growth
- ULY N/A
- SXTP N/A
- EPS
- ULY N/A
- SXTP N/A
- Revenue
- ULY $131,235,000.00
- SXTP $984,494.00
- Revenue This Year
- ULY N/A
- SXTP $81.41
- Revenue Next Year
- ULY $20.23
- SXTP $83.17
- P/E Ratio
- ULY N/A
- SXTP N/A
- Revenue Growth
- ULY N/A
- SXTP 128.70
- 52 Week Low
- ULY $2.41
- SXTP $1.22
- 52 Week High
- ULY $17.99
- SXTP $12.45
- Technical
- Relative Strength Index (RSI)
- ULY 32.15
- SXTP 35.26
- Support Level
- ULY $2.64
- SXTP $1.43
- Resistance Level
- ULY $3.07
- SXTP $1.52
- Average True Range (ATR)
- ULY 0.23
- SXTP 0.07
- MACD
- ULY 0.00
- SXTP -0.03
- Stochastic Oscillator
- ULY 13.41
- SXTP 0.00
About ULY Urgent.ly Inc.
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.